Marina Deodato, MD

Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Italy

Poster(s):

• 1403 - Factors Influencing the Regimen choice for firSt-line Therapy in Chronic Lymphocytic Leukemia: the FIRST-CLL study

• 1708 - Chronic Obstructive Pulmonary Disease and Previous Pneumonia have an impact on infectious complications in patients with Chronic Lymphocytic Leukemia treated with Acalabrutinib and Zanubrutinib: a Multicentre SEIFEM Study.

• 1907 - Autoimmune cytopenias in patients with chronic lymphocytic leukemia receiving acalabrutinib treatment.